InsidersTradesSigma
Track the CanSino Biologics Inc. stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, CanSino Biologics Inc. has published 3 reports. Market capitalisation: €5.8bn. The latest transaction was disclosed on 30 March 2026 (Purchase). Among the most active insiders: Chao Shou Bai. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
CanSino Biologics Inc. is a biopharmaceutical company focused on the development of innovative vaccines and therapies. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.